SLNO Surges on Acquisition Speculation, Deal News Boosts Individual Stocks

Deep News04-06 21:50

Soleno Therapeutics (SLNO) became a market focus during Monday's early trading session, with its shares rising sharply by 26% in pre-market activity driven by deal negotiation reports. Reports indicated that Neurocrine Biosciences is in advanced talks to acquire the company, with a potential valuation exceeding $2.5 billion, or a price per share in the low-to-mid $50 range. If finalized, the deal would grant Neurocrine access to Soleno's treatment for Prader-Willi syndrome, which analysts project could achieve peak annual sales of $2.3 billion. Other individual stocks also displayed a more positive market tone. Twilio (TWLO) gained approximately 3% after Jefferies upgraded the stock to "buy" and set a $160 price target, citing its stronger positioning in voice AI and improving fundamentals. Netflix also rose about 2% following an upgrade to "buy" by Goldman Sachs, which highlighted improved growth visibility, margin expansion potential, and the possibility of share repurchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168529932?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-06 21:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168529932","market":"sg","top_or_hot":-1,"title":"SLNO Surges on Acquisition Speculation, Deal News Boosts Individual Stocks","media":"Deep News","content":"<p>Soleno Therapeutics (SLNO) became a market focus during Monday's early trading session, with its shares rising sharply by 26% in pre-market activity driven by deal negotiation reports.\nReports indicated that Neurocrine Biosciences is in advanced talks to acquire the company, with a potential valuation exceeding $2.5 billion, or a price per share in the low-to-mid $50 range. If finalized, the deal would grant Neurocrine access to Soleno's treatment for Prader-Willi syndrome, which analysts project could achieve peak annual sales of $2.3 billion.\nOther individual stocks also displayed a more positive market tone. Twilio (TWLO) gained approximately 3% after Jefferies upgraded the stock to \"buy\" and set a $160 price target, citing its stronger positioning in voice AI and improving fundamentals. Netflix also rose about 2% following an upgrade to \"buy\" by Goldman Sachs, which highlighted improved growth visibility, margin expansion potential, and the possibility of share repurchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SLNO Surges on Acquisition Speculation, Deal News Boosts Individual Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSLNO Surges on Acquisition Speculation, Deal News Boosts Individual Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-04-06 21:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Soleno Therapeutics (SLNO) became a market focus during Monday's early trading session, with its shares rising sharply by 26% in pre-market activity driven by deal negotiation reports.\nReports indicated that Neurocrine Biosciences is in advanced talks to acquire the company, with a potential valuation exceeding $2.5 billion, or a price per share in the low-to-mid $50 range. If finalized, the deal would grant Neurocrine access to Soleno's treatment for Prader-Willi syndrome, which analysts project could achieve peak annual sales of $2.3 billion.\nOther individual stocks also displayed a more positive market tone. Twilio (TWLO) gained approximately 3% after Jefferies upgraded the stock to \"buy\" and set a $160 price target, citing its stronger positioning in voice AI and improving fundamentals. Netflix also rose about 2% following an upgrade to \"buy\" by Goldman Sachs, which highlighted improved growth visibility, margin expansion potential, and the possibility of share repurchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1168529932","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168529932","pubTimestamp":1775483458,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Soleno Therapeutics (SLNO) became a market focus during Monday's early trading session, with its shares rising sharply by 26% in pre-market activity driven by deal negotiation reports. Reports...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","SLNO":"Soleno Therapeutics"},"translate_title":"SLNO因收购猜测而飙升，交易消息提振个股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SLNO":1},"content_text":"Soleno Therapeutics (SLNO) became a market focus during Monday's early trading session, with its shares rising sharply by 26% in pre-market activity driven by deal negotiation reports.\nReports indicated that Neurocrine Biosciences is in advanced talks to acquire the company, with a potential valuation exceeding $2.5 billion, or a price per share in the low-to-mid $50 range. If finalized, the deal would grant Neurocrine access to Soleno's treatment for Prader-Willi syndrome, which analysts project could achieve peak annual sales of $2.3 billion.\nOther individual stocks also displayed a more positive market tone. Twilio (TWLO) gained approximately 3% after Jefferies upgraded the stock to \"buy\" and set a $160 price target, citing its stronger positioning in voice AI and improving fundamentals. Netflix also rose about 2% following an upgrade to \"buy\" by Goldman Sachs, which highlighted improved growth visibility, margin expansion potential, and the possibility of share repurchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168529932","isCrawlerRequest":true}